Related Experiment Video
Updated: Aug 16, 2025

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
TIPARP is involved in the regulation of intraocular pressure
Youjia Zhang1,2, Maomao Song1,2, Yingwen Bi3
1Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, 200031, China.
Abstract:
Elevated intraocular pressure (IOP) is the major risk factor for glaucoma. The molecular mechanism of elevated IOP is unclear, which impedes glaucoma therapy. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible Poly-ADP-ribose Polymerase (TIPARP), a member of the PARP family, catalyses mono-ADP-ribosylation. Here we showed that TIPARP was widely expressed in the cornea, trabecular meshwork, iris, retina, optic nerve, sclera, and choroid of human eyes. The expression of TIPARP was significantly upregulated in the blood and trabecular meshwork of patients with primary open angle glaucoma compared with that of healthy controls. Transcriptome analysis revealed that the expression of genes related to extracellular matrix deposition and cell adhesion was decreased in TIPARP-upregulated human trabecular meshwork (HTM) cells. Moreover, western blot analysis showed that collagen types I and IV, fibronectin, and α-SMA were increased in TIPARP-downregulated or TIPARP-inhibited HTM cells. In addition, cross-linked actin networks were produced, and vinculin was upregulated in these cells. Subconjunctival injection of the TIPARP inhibitor RBN-2397 increased the IOP in Sprague-Dawley rats. Therefore, we identified TIPARP as a regulator of IOP through modulation of extracellular matrix and cell cytoskeleton proteins in HTM cells. These results indicate that TIPARP is a potential therapeutic target for ocular hypertension and glaucoma.
Insights
Elevated intraocular pressure (IOP), a glaucoma risk factor, is linked to TIPARP. Inhibiting TIPARP in human trabecular meshwork cells altered extracellular matrix and cytoskeleton proteins, suggesting TIPARP as a therapeutic target.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- Elevated intraocular pressure (IOP) is the primary risk factor for glaucoma, but its molecular mechanisms remain poorly understood, hindering effective therapies.
- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible Poly-ADP-ribose Polymerase (TIPARP) is a PARP family member involved in mono-ADP-ribosylation.
Purpose of the Study:
- To investigate the role of TIPARP in the molecular mechanisms of elevated IOP and its potential as a therapeutic target for glaucoma.
- To examine TIPARP expression in human ocular tissues and its association with primary open-angle glaucoma.
Main Methods:
- Western blot and transcriptome analysis were used to assess TIPARP expression and its downstream effects on extracellular matrix and cytoskeleton proteins in human trabecular meshwork (HTM) cells.
- TIPARP expression levels were analyzed in ocular tissues and blood from glaucoma patients and healthy controls.
- The effect of a TIPARP inhibitor (RBN-2397) on IOP was evaluated in a rat model.
Main Results:
- TIPARP was expressed in various human eye tissues and significantly upregulated in the blood and trabecular meshwork of primary open-angle glaucoma patients.
- Downregulation or inhibition of TIPARP in HTM cells led to decreased expression of genes related to extracellular matrix deposition and cell adhesion, and increased levels of collagen, fibronectin, and α-SMA.
- TIPARP inhibition also resulted in the production of cross-linked actin networks and upregulation of vinculin in HTM cells.
- Subconjunctival injection of the TIPARP inhibitor RBN-2397 increased IOP in rats.
Conclusions:
- TIPARP acts as a regulator of IOP by modulating extracellular matrix and cell cytoskeleton proteins within HTM cells.
- These findings identify TIPARP as a promising therapeutic target for managing ocular hypertension and glaucoma.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hypertension and Regulation of Blood Pressure
Angle Closure Glaucoma: Treatment

